烧伤儿童药物镇静镇痛的现状及研究进展

贾梦倩; 袁心刚

doi:10.3760/cma.j.cn501120-20200908-00404

烧伤儿童药物镇静镇痛的现状及研究进展

doi: 10.3760/cma.j.cn501120-20200908-00404

贾梦倩,
袁心刚^,

重庆医科大学附属儿童医院烧伤整形外科，儿童发育疾病研究教育部重点实验室，国家儿童健康与疾病临床医学研究中心，儿童发育重大疾病国家国际科技合作基地，儿科学重庆市重点实验室，重庆　　400014

基金项目:

重庆市卫生计生委医学科研项目 20142043

详细信息

通讯作者:
袁心刚，Email：yuanxinggang1977@qq.com

计量
- 文章访问数: 449
- HTML全文浏览量: 76
- PDF下载量: 124
- 被引次数: 0
出版历程
- 收稿日期: 2020-09-08

Current status and research advances on drug sedation and analgesia in burn children

Jia Mengqian,
Yuan Xingang^,

Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Department of Burns and Plastic Surgery, Children′s Hospital of Chongqing Medical University, Chongqing 400014, China

Funds:

Scientific Research Project of Chongqing Health and Family Planning Commission 20142043

More Information

Corresponding author: Yuan Xingang, Email: yuanxinggang1977@qq.com

摘要

摘要: 儿童是烧伤的高发人群，具有独特的生理、心理和解剖状态，对烧伤儿童的焦虑和疼痛管理极具挑战。非药物干预在烧伤儿童的疼痛管理中很重要，但通常不足以充分治疗疼痛和焦虑，因此药物镇静镇痛是必需的。本综述回顾了该领域国内外近10年来临床治疗及科研进展，包括对烧伤儿童的疼痛评估，镇静镇痛治疗中的监护、主要的治疗药物及研究进展、临床实践中的一些争议，并提出一些建议，以供临床参考。
- 烧伤 /
- 儿童 /
- 疼痛 /
- 镇静镇痛 /
- 药物干预
Abstract: Children are high-risk groups of burns, with unique physiological, psychological, and anatomical states, and the management of anxiety and pain for burn children are extremely challenging. Non-pharmacological interventions are very important for pain management in burn children, but are often inadequate for treating pain and anxiety, so pharmacological sedation and analgesia are necessary. This article reviewed the clinical treatment and research progress in this field in the past 10 years at home and abroad, including the pain assessment of burn children, monitoring in sedative and analgesic treatment, main therapeutic drugs and research progress, and some controversies in clinical practice. Besides, some suggestions have been put forward for clinical reference.
- Burns /
- Child /
- Pain /
- Sedation and analgesia /
- Drug intervention
所有作者均声明不存在利益冲突

HTML全文

表1 烧伤儿童常用的部分镇静药物及其拮抗药物的使用情况和注意事项

药物分类及名称	用药方法及剂量	起效时间（min）	效果持续时间（min）	注意事项
苯二氮卓类
咪达唑仑	静脉推注：0.5~5岁初始剂量为0.05~0.1 mg/kg，然后滴定至最大剂量0.6 mg/kg；6~12岁初始剂量为0.025~0.05 mg/kg，然后滴定至最大剂量0.40 mg/kg	2~3	45~60	与阿片类药物合用时减少剂量
	肌内注射：每次0.10~0.15 mg/kg	10~20	60~120
	口服：每次0.5~0.75 mg/kg	15~30	60~90
	滴鼻：每次0.2~0.5 mg/kg	10~15	60
	直肠给药：每次0.25~0.5 mg/kg	10~30	60~90
地西泮	静脉推注：初始剂量0.05~0.1 mg/kg，然后慢慢滴定至最大剂量0.25 mg/kg	4~5	60~120	与阿片类药物合用时减少剂量
苯二氮卓类拮抗药
氟马西尼	静脉推注：每次0.02 mg/kg，根据需要可每分钟重复给药1次，总剂量最多1 mg	1~2	30~60	如作用时间短于所拮抗的药物，则可能需要连续给药
α2肾上腺素能激动剂
右美托咪定	静脉推注：初始剂量0.3~1 μg/kg，推注时间10~15 min，随后以0.1~0.6 μg·kg^-1·h^-1的剂量滴注	10~15	—	与扩血管药物、负性频率药物同时使用时应谨慎，避免突然停药，最长给药时间24 h
水合氯醛	口服：每次25~100 mg/kg，30 min后可重复给药25~50 mg/kg，总剂量最多2 g或100 mg/kg（以较少者为准）	15~30	60~120	禁止与呋塞米同时使用
丙泊酚	静脉推注：初始剂量1.0 mg/kg，然后可根据需要按照0.5 mg/kg剂量重复给药	<1	5~15	鸡蛋或蛋制品及大豆或豆制品过敏者避免使用
注：该表引自文献[6,12, 13, 14]，“—”表示维持剂量可持续起效；药品的使用说明及禁忌证、不良反应详见药品说明书

下载: 导出CSV

表2 烧伤儿童常用的部分镇痛药物及其拮抗药物的使用情况和注意事项

药物分类及名称	用药方法及剂量	起效时间（min）	效果持续时间（min）	注意事项
阿片类
芬太尼	静脉推注：每次1.0 g/kg（最多不超过50 g），可每3分钟重复给药1次	3~5	30~60	与苯二氮卓类药物合用时减少剂量
吗啡	静脉推注：每次0.05~0.15 mg/kg（最多不超过3 mg），可每5分钟重复给药1次	5~10	120~180	与苯二氮卓类药物合用时减少剂量
阿片类拮抗药
纳洛酮	静脉推注或肌内注射：每次0.1 mg，每次最多2 mg，根据需要每2分钟重复1次	静脉推注：2	静脉推注：20~40，肌内注射：60~90	如作用时间短于所拮抗的药物，则可能需要连续给药
解离性药物
氯胺酮	静脉推注：1~1.5 mg/kg，推注时间>1 min，根据需要每10分钟重复1次；肌内注射：初始剂量45 mg/kg，10 min后可按2~4 mg/kg重复给药	1	静脉推注：5~10，肌内注射：12~25	对血压升高会造成危险的患者禁用，休克失代偿期、心功能不全的患者禁用，给药前后24 h禁酒
氯胺酮		3~5	静脉推注：5~10，肌内注射：12~25	对血压升高会造成危险的患者禁用，休克失代偿期、心功能不全的患者禁用，给药前后24 h禁酒
吸入药物
一氧化二氮	含至少体积分数30%氧气的混合物，持续面罩供给（不合作儿童使用鼻罩供给）	<5	停药后<5	需要专门的气体供应设备和气体清除设备
非甾体类抗炎药
布洛芬	口服或直肠给药：15 mg/kg	—	—	心脏手术前后禁用，过敏者禁用
对乙酰氨基酚	口服或直肠给药：15~20 mg/kg，静脉推注：不超过100 mg·kg^-1·d^-1	—	—	12岁以下不推荐使用，肝肾功不全及过敏体质者慎用，禁止与乙醇及含乙醇的饮料同时使用
注：该表引自文献[6,12, 13, 14]，“—”表示文献中未提到；文献中未提到肌内注射纳洛酮的起效时间；药品的使用说明及禁忌证、不良反应详见药品说明书

下载: 导出CSV

参考文献(32)

[1]	KudchadkarSR,AljohaniOA,PunjabiNM.Sleep of critically ill children in the pediatric intensive care unit: a systematic review[J].Sleep Med Rev,2014,18(2):103-110.DOI: 10.1016/j.smrv.2013.02.002.
[2]	《中华烧伤杂志》编辑委员会.成人烧伤疼痛管理指南(2013版)[J].中华烧伤杂志,2013,29(3):225-231.DOI: 10.3760/cma.j.issn.1009-2587.2013.03.002.
[3]	ISBI Practice Guidelines Committee, SubcommitteeAdvisory, SubcommitteeSteering. ISBI practice guidelines for burn care, part 2[J].Burns,2018,44(7):1617-1706.DOI: 10.1016/j.burns.2018.09.012.
[4]	Gamst-JensenH,VedelPN,Lindberg-LarsenVO,et al.Acute pain management in burn patients: appraisal and thematic analysis of four clinical guidelines[J].Burns,2014,40(8):1463- 1469.DOI: 10.1016/j.burns.2014.08.020.
[5]	中华医学会儿科学分会急救学组,中华医学会急诊医学分会儿科学组,中国医师协会儿童重症医师分会.中国儿童重症监护病房镇痛和镇静治疗专家共识(2018版)[J].中华儿科杂志,2019,57(5):324-330.DOI: 10.3760/cma.j.issn.0578-1310.2019.05.002.
[6]	FaginA,PalmieriTL.Considerations for pediatric burn sedation and analgesia[J/OL].Burns Trauma,2017,5:28[2020-09-08].https://pubmed.ncbi.nlm.nih.gov/29051890/.DOI:10.1186/s41038- 017-0094-8.
[7]	LuffyR,GroveSK.Examining the validity, reliability, and preference of three pediatric pain measurement tools in African-American children[J].Pediatr Nurs,2003,29(1):54-59.
[8]	de JongA,BaartmansMJ,BremerM,et al.Reliability, validity and clinical utility of three types of pain behavioural observation scales for young children with burns aged 0-5 years[J].Pain,2010,150(3):561-567.DOI: 10.1016/j.pain.2010.06.016.
[9]	van der HeijdenMJE,de JongA,RodeH,et al.Assessing and addressing the problem of pain and distress during wound care procedures in paediatric patients with burns[J].Burns,2018,44(1):175-182.DOI: 10.1016/j.burns.2017.07.004.
[10]	ShenJ,GilesSA,KurtovicK,et al.Evaluation of nurse accuracy in rating procedural pain among pediatric burn patients using the Face, Legs, Activity, Cry, Consolability (FLACC) Scale[J].Burns,2017,43(1):114-120.DOI: 10.1016/j.burns.2016.07.009.
[11]	FranckLS,BruceE.Putting pain assessment into practice: why is it so painful?[J].Pain Res Manag,2009,14(1):13-20.DOI: 10.1155/2009/856587.
[12]	KraussB,GreenSM.Procedural sedation and analgesia in children[J].Lancet,2006,367(9512):766-780.DOI: 10.1016/S0140-6736(06)68230-5.
[13]	BayatA,RamaiahR,BhanankerSM.Analgesia and sedation for children undergoing burn wound care[J].Expert Rev Neurother,2010,10(11):1747-1759.DOI: 10.1586/ern.10.158.
[14]	PardesiO,FuzaylovG.Pain management in pediatric burn patients: review of recent literature and future directions[J].J Burn Care Res,2017,38(6):335-347.DOI: 10.1097/BCR.0000000000000470.
[15]	BroadisE,ChokothoT,BorgsteinE.Paediatric burn and scald management in a low resource setting: a reference guide and review[J].Afr J Emerg Med,2017,7(Suppl):S27-31.DOI: 10.1016/j.afjem.2017.06.004.
[16]	KhanA,ParikhM,MinhajuddinA,et al.Opioid prescribing practices in a pediatric burn tertiary care facility: is it time to change?[J].Burns,2020,46(1):219-224.DOI: 10.1016/j.burns.2019.07.016.
[17]	SingletonA,PrestonRJ,CochranA.Sedation and analgesia for critically ill pediatric burn patients: the current state of practice[J].J Burn Care Res,2015,36(3):440-445.DOI: 10.1097/BCR.0000000000000165.
[18]	GrossmannB,NilssonA,SjöbergF,et al.Rectal ketamine during paediatric burn wound dressing procedures: a randomised dose-finding study[J].Burns,2019,45(5):1081-1088.DOI: 10.1016/j.burns.2018.12.012.
[19]	NemethM,JacobsenN,BantelC,et al.Intranasal analgesia and sedation in pediatric emergency care-a prospective observational study on the implementation of an institutional protocol in a tertiary children's hospital[J].Pediatr Emerg Care,2019,35(2):89-95.DOI: 10.1097/PEC.0000000000001017.
[20]	SeolTK,LimJK,YooEK,et al.Propofol-ketamine or propofol-remifentanil for deep sedation and analgesia in pediatric patients undergoing burn dressing changes: a randomized clinical trial[J].Paediatr Anaesth,2015,25(6):560- 566.DOI: 10.1111/pan.12592.
[21]	NorambuenaC,YañezJ,FloresV,et al.Oral ketamine and midazolam for pediatric burn patients: a prospective, randomized, double-blind study[J].J Pediatr Surg,2013,48(3):629-634.DOI: 10.1016/j.jpedsurg.2012.08.018.
[22]	CanpolatDG,EsmaogluA,TosunZ,et al.Ketamine-propofol vs ketamine-dexmedetomidine combinations in pediatric patients undergoing burn dressing changes[J].J Burn Care Res,2012,33(6):718-722.DOI: 10.1097/BCR.0b013e3182504316.
[23]	SchieveldJN,StrikJJ.Pediatric delirium: a worldwide PICU problem[J].Crit Care Med,2017,45(4):746-747.DOI: 10.1097/CCM.0000000000002275.
[24]	SmithHAB,GangopadhyayM,GobenCM,et al.Delirium and benzodiazepines associated with prolonged ICU stay in critically ill infants and young children[J].Crit Care Med,2017,45(9):1427-1435.DOI: 10.1097/CCM.0000000000002515.
[25]	MottaE,LuglioM,DelgadoAF,et al.Importance of the use of protocols for the management of analgesia and sedation in pediatric intensive care unit[J].Rev Assoc Med Bras (1992),2016,62(6):602-609.DOI: 10.1590/1806-9282.62.06.602.
[26]	VetNJ,IstaE,de WildtSN,et al.Optimal sedation in pediatric intensive care patients: a systematic review[J].Intensive Care Med,2013,39(9):1524-1534.DOI: 10.1007/s00134-013-2971-3.
[27]	吴巍巍,路英慧,程丹,等.烧伤患儿的疼痛评估及非药物干预研究进展[J].中华烧伤杂志,2020,36(1):76-80.DOI: 10.3760/cma.j.issn.1009-2587.2020.01.015.
[28]	CotéCJ,NottermanDA,KarlHW,et al.Adverse sedation events in pediatrics: a critical incident analysis of contributing factors[J].Pediatrics,2000,105(4 Pt 1):805-814.DOI: 10.1542/peds.105.4.805.
[29]	SchwartzKR,FredricksK,Al TawilZ,et al.An innovative safe anesthesia and analgesia package for emergency pediatric procedures and surgeries when no anesthetist is available[J].Int J Emerg Med,2016,9(1):16.DOI: 10.1186/s12245-016-0113-8.
[30]	O'HaraD,GaneshalingamK,GerrishH,et al.A 2 year experience of nurse led conscious sedation in paediatric burns[J].Burns,2014,40(1):48-53.DOI: 10.1016/j.burns.2013.08.021.
[31]	ThompsonEM,AndrewsDD,Christ-LibertinC.Efficacy and safety of procedural sedation and analgesia for burn wound care[J].J Burn Care Res,2012,33(4):504-509.DOI: 10.1097/BCR.0b013e318236fe4f.
[32]	DissanaikeS.Is it ethical to treat pain differently in children and adults with burns?[J].AMA J Ethics,2018,20(6):531-536.DOI: 10.1001/journalofethics.2018.20.6.cscm1-1806.